1. Home
  2. SPIR vs SLN Comparison

SPIR vs SLN Comparison

Compare SPIR & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPIR
  • SLN
  • Stock Information
  • Founded
  • SPIR 2012
  • SLN 1994
  • Country
  • SPIR United States
  • SLN United Kingdom
  • Employees
  • SPIR N/A
  • SLN N/A
  • Industry
  • SPIR Telecommunications Equipment
  • SLN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPIR Consumer Discretionary
  • SLN Health Care
  • Exchange
  • SPIR Nasdaq
  • SLN Nasdaq
  • Market Cap
  • SPIR 251.8M
  • SLN 165.3M
  • IPO Year
  • SPIR N/A
  • SLN N/A
  • Fundamental
  • Price
  • SPIR $9.53
  • SLN $3.56
  • Analyst Decision
  • SPIR Strong Buy
  • SLN Buy
  • Analyst Count
  • SPIR 5
  • SLN 5
  • Target Price
  • SPIR $16.25
  • SLN $40.80
  • AVG Volume (30 Days)
  • SPIR 588.8K
  • SLN 265.6K
  • Earning Date
  • SPIR 05-19-2025
  • SLN 05-08-2025
  • Dividend Yield
  • SPIR N/A
  • SLN N/A
  • EPS Growth
  • SPIR N/A
  • SLN N/A
  • EPS
  • SPIR N/A
  • SLN N/A
  • Revenue
  • SPIR $110,451,000.00
  • SLN $27,701,000.00
  • Revenue This Year
  • SPIR $2.24
  • SLN N/A
  • Revenue Next Year
  • SPIR $25.73
  • SLN N/A
  • P/E Ratio
  • SPIR N/A
  • SLN N/A
  • Revenue Growth
  • SPIR 13.15
  • SLN 36.71
  • 52 Week Low
  • SPIR $6.26
  • SLN $1.97
  • 52 Week High
  • SPIR $21.43
  • SLN $24.38
  • Technical
  • Relative Strength Index (RSI)
  • SPIR 51.34
  • SLN 52.27
  • Support Level
  • SPIR $9.04
  • SLN $3.73
  • Resistance Level
  • SPIR $10.13
  • SLN $4.15
  • Average True Range (ATR)
  • SPIR 0.68
  • SLN 0.33
  • MACD
  • SPIR 0.05
  • SLN 0.07
  • Stochastic Oscillator
  • SPIR 46.04
  • SLN 45.45

About SPIR Spire Global Inc.

Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: